Company Encyclopedia
View More
name
Inari Medical
NARI.US
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons.
1.407 T
NARI.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking0/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-17.72%E
    • Profit Margin-13.68%D
    • Gross Margin87.06%A
  • Growth ScoreB
    • Revenue YoY22.41%A
    • Net Profit YoY-2737.92%E
    • Total Assets YoY27.04%A
    • Net Assets YoY-3.84%D
  • Cash ScoreC
    • Cash Flow Margin-731.08%E
    • OCF YoY22.41%A
  • Operating ScoreA
    • Turnover0.92A
  • Debt ScoreB
    • Gearing Ratio37.65%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    SANAN plans to jointly acquire 100% equity of Lumileds Holding B.V. from Inari for a transaction price of USD 239 million

    SANAN plans to jointly acquire 100% equity of Lumileds Holding B.V. for USD 239 million in cash with Inari, and jointly invest USD 280 million to establish a joint venture in Hong Kong. Upon completion of the transaction, SANAN will indirectly hold 74.5% equity of Lumileds. The target company focuses on the production and sales of mid-to-high-end LED products, and the acquisition will enhance its global supply chain layout

    Zhitong·
    SH
    600703
    +0.68%
    US
    NARI
    0.00%
    Zhitong·
    SH
    600703
    +0.68%
    US
    NARI
    0.00%

    San’an and Inari to Acquire 100% of Lumileds Holding B.V.’s Shares

    San’an Optoelectronics and Inari Amertron Berhad have announced a definitive agreement to acquire 100% of Lumileds Holding B.V. and its subsidiaries. The transaction aims to enhance Lumileds' growth in the evolving LED industry and is expected to close by Q1 2026, pending customary conditions. Lumileds is a leader in LED technology, while San’an and Inari are prominent players in the semiconductor and LED markets, respectively.

    MorningStar·
    US
    NARI
    0.00%
    MorningStar·
    US
    NARI
    0.00%

    Inari Medical, Stryker Subsidiary, Launches New InThrill Thrombectomy System

    Inari Medical, a subsidiary of Stryker Corporation, has launched the InThrill® Thrombectomy System, designed for arteriovenous access and small vessel thrombus cases. This 8 French over-the-wire system features enhanced radial force, optimized clot capture, and improved ergonomics. The first commercial use was successfully performed by Dr. Joshua Pinter and Dr. Anish Ghodadra at UPMC, marking a significant advancement in thrombectomy procedures.

    Reuters·
    US
    NARI
    0.00%
    Reuters·
    US
    NARI
    0.00%

    Short selling in five counters suspended amid market rout Intraday short selling in five counters, namely UWC Bhd (KL:UWC), Inari Amertron Bhd (KL:INARI), Guan Chong Bhd (KL:GCB), Pentamaster Corporation Bhd (KL:PENTA) and Pavilion Real Estate Investment Trust (KL:PAVREIT), was suspended on Monday after all five saw an at least 15% drop in their share prices.

    Intraday short selling in five companies, including UWC Bhd, Inari Amertron Bhd, Guan Chong Bhd, Pentamaster Corporation Bhd, and Pavilion REIT, was suspended after each experienced a drop of at least 15% in share prices. The suspension will be lifted at 8:30 am on Tuesday. This decline is part of a broader market downturn, with significant losses across various indices, attributed to fears of a global trade war.

    The Edge Malaysia·
    US
    NARI
    0.00%
    The Edge Malaysia·
    US
    NARI
    0.00%

    Inari Welcomes Dr. Vivien Bonazzi as Chief Data Officer

    Unusual Whales·
    US
    NARI
    0.00%
    Unusual Whales·
    US
    NARI
    0.00%
    © 2025 Longbridge｜Disclaimer